Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects

Recent studies have highlighted the successes of chimeric antigen receptor-modified T- (CART-) cell-based therapy for B-cell malignancies, and early phase clinical trials have been launched in recent years. The few published clinical studies of CART cells in solid tumors have addressed safety and fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yelei, Wang, Yao, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779545/
https://www.ncbi.nlm.nih.gov/pubmed/26998495
http://dx.doi.org/10.1155/2016/3850839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779545/
https://www.ncbi.nlm.nih.gov/pubmed/26998495
http://dx.doi.org/10.1155/2016/3850839

Ejemplares similares